Voyager Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Voyager Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q2 2019 to Q3 2025.
  • Voyager Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2025 was $6.81M.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)

Voyager Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $6.81M Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $7.47M Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $8.15M Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $8.87M Dec 31, 2024 10-K 2025-03-11
Q4 2021 $12.4M -$3.54M -22.1% Dec 31, 2021 10-K 2022-03-08
Q3 2021 $13.3M +$3.77M +39.4% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $14.1M +$3.88M +37.9% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $15M +$4.1M +37.4% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $16M +$4.32M +37% Dec 31, 2020 10-K 2021-02-25
Q3 2020 $9.56M -$2.83M -22.8% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $10.2M -$2.89M -22% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $10.9M Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $11.7M Dec 31, 2019 10-K 2020-03-03
Q3 2019 $12.4M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $13.1M Jun 30, 2019 10-Q 2019-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.